阿尔茨海默病风险预测和病原体提取使用模糊图形进化生成对抗网络
IEEE transactions on neural networks and learning systems
|November 12, 2025
概括
这项研究引入了一种新的模糊图形进化生成对抗网络 (FGE-GAN),用于预测阿尔茨海默病 (AD) 风险. FGE-GAN模型增强了对AD病原学的理解,并改善了早期干预策略.
科学领域:
- 计算神经科学是一种计算神经科学.
- 医学中的人工智能
- 生物信息学是一种生物信息学.
背景情况:
- 准确预测阿尔茨海默病 (AD) 风险对于临床管理至关重要.
- 疾病数据的模糊性阻碍了对AD病原学的全面理解,并限制了预测模型的有效性.
研究的目的:
- 通过整合模糊图形理论和深度学习来开发阿尔茨海默病 (AD) 风险预测的先进模型.
- 探索阿尔茨海默病的阶段性进化模式,并提取早期干预的病原学见解.
主要方法:
- 使用模糊图表来通过模糊成员身份量化病原体间的关联.
- 开发了一个模糊的传播模型来描述AD恶化随着模糊的传播.
- 引入了一个模糊图形进化生成对抗网络 (FGE-GAN) 与模糊图形卷积 (FGC) 层,用于风险预测和病原体提取.
主要成果:
- 与现有的最先进的方法相比,FGE-GAN模型在疾病风险预测方面表现优越.
- 对脑疾病数据集的实验验验证了该模型的有效性.
- 提取的多基因病原学因素为早期AD干预提供了宝贵的见解.
结论:
- 拟议的FGE-GAN提供了一种可解释和有效的方法来预测阿尔茨海默病 (AD) 风险.
- 模糊图形建模和深度学习的整合有助于我们更好地理解AD的发病过程.
- 该模型提取病原体洞察力的能力支持开发有针对性的早期干预策略.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.4K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.6K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782
Dementia
503
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
503
